Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.

× No keyword cloud information.

31 in total

Review 1. Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.

Authors: Jordan Loader; Frances C Taylor; Erik Lampa; Johan Sundström
Journal: J Am Heart Assoc Date: 2022-05-27 Impact factor: 6.106

2. Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.

Authors: Nathalie Gault; Marina Esposito-Farèse; Matthieu Revest; Jocelyn Inamo; André Cabié; Élisabeth Polard; Jean-Sébastien Hulot; Jade Ghosn; Catherine Chirouze; Laurène Deconinck; Jean-Luc Diehl; Julien Poissy; Olivier Epaulard; Benjamin Lefèvre; Lionel Piroth; Etienne De Montmollin; Eric Oziol; Manuel Etienne; Cédric Laouénan; Patrick Rossignol; Dominique Costagliola; Emmanuelle Vidal-Petiot
Journal: Fundam Clin Pharmacol Date: 2021-05-16 Impact factor: 2.747

3. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.

Authors: Francesco P Cappuccio; Alfonso Siani
Journal: Nutr Metab Cardiovasc Dis Date: 2020-05-29 Impact factor: 4.222

4. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.

Authors: Raymond Pranata; Hikmat Permana; Ian Huang; Michael Anthonius Lim; Nanny Natalia M Soetedjo; Rudi Supriyadi; Arto Yuwono Soeroto; Amir Aziz Alkatiri; Doni Firman; Antonia Anna Lukito
Journal: Diabetes Metab Syndr Date: 2020-06-27

5. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis.

Authors: Lu Ren; Shandong Yu; Wilson Xu; James L Overton; Nipavan Chiamvimonvat; Phung N Thai
Journal: J Cardiol Date: 2020-11-02 Impact factor: 3.159

6. Comparison of renin-angiotensin-aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes.

Authors: Yihienew M Bezabih; Alemayehu Bezabih; Endalkachew Alamneh; Gregory M Peterson; Woldesellassie Bezabhe
Journal: BMC Infect Dis Date: 2021-06-05 Impact factor: 3.090

7. Renin-angiotensin-aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis.

Authors: Upinder Kaur; Sankha Shubhra Chakrabarti; Tejas K Patel
Journal: Ther Adv Drug Saf Date: 2021-05-14

8. Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?

Authors: Stephan Katzenschlager; Alexandra J Zimmer; Claudius Gottschalk; Jürgen Grafeneder; Stephani Schmitz; Sara Kraker; Marlene Ganslmeier; Amelie Muth; Alexander Seitel; Lena Maier-Hein; Andrea Benedetti; Jan Larmann; Markus A Weigand; Sean McGrath; Claudia M Denkinger
Journal: PLoS One Date: 2021-07-29 Impact factor: 3.240

9. Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?

Authors: Stephan Katzenschlager; Alexandra J Zimmer; Claudius Gottschalk; Juergen Grafeneder; Alexander Seitel; Lena Maier-Hein; Andrea Benedetti; Jan Larmann; Markus A Weigand; Sean McGrath; Claudia M Denkinger
Journal: medRxiv Date: 2020-11-12

Review 10. Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era.

Authors: S Greco; A Madè; C Gaetano; Y Devaux; C Emanueli; F Martelli
Journal: J Transl Med Date: 2020-10-31 Impact factor: 5.531